Multiple approaches for simplifying the serum proteome have been described. These techniques are generally developed across different laboratories, samples, mass spectrometry platforms, and analysis tools. Hence, comparing the available schemes is impossible from the existing literature because of confounding variables. We describe a head-to-head comparison of several serum fractionation schemes, including N-linked glycopeptide enrichment, cysteinyl-peptide enrichment, magnetic bead separation (C3, C8, and WCX), size fractionation, protein A/G depletion, and immunoaffinity column depletion of abundant serum proteins. Each technique was compared to results obtained from unfractionated human serum. The results show immunoaffinity subtraction ...
The enormous depth complexity of the human plasma proteome poses a significant challenge for current...
mAb proteomics, a reversed biomarker discovery approach, is a novel methodology torecognize the prot...
Serum provides a rich source of potential biomarker proteoforms. One of the major obstacles in analy...
In most diseases, the clinical need for serum/plasma markers has never been so crucial, not only for...
BACKGROUND: To date, the complexity of the plasma proteome exceeds the analytical capacity of conven...
The ability to cure or manage many diseases is highly dependent on the ability to correctly diagnose...
Off-line sample prefractionations applied prior to biomarker discovery proteomics are options to ena...
To date, the complexity of the plasma proteome exceeds the analytical capacity of conventional appro...
AbstractOff-line sample prefractionations applied prior to biomarker discovery proteomics are option...
Serum is the body fluid most often used in biomarker discovery. Albumin, the most abundant serum pro...
BACKGROUND: To date, the complexity of the plasma proteome exceeds the analytical capacity of conve...
Discovery and validation of plasma biomarkers are quite challenging because of the high complexity a...
Characterisation of blood serum peptides can provide valuable information on physiological and patho...
Serum potentially carries an archive of important histo-logical information whose determination coul...
Changes in serum proteins that signal histopathological states, such as cancer, are useful diagnosti...
The enormous depth complexity of the human plasma proteome poses a significant challenge for current...
mAb proteomics, a reversed biomarker discovery approach, is a novel methodology torecognize the prot...
Serum provides a rich source of potential biomarker proteoforms. One of the major obstacles in analy...
In most diseases, the clinical need for serum/plasma markers has never been so crucial, not only for...
BACKGROUND: To date, the complexity of the plasma proteome exceeds the analytical capacity of conven...
The ability to cure or manage many diseases is highly dependent on the ability to correctly diagnose...
Off-line sample prefractionations applied prior to biomarker discovery proteomics are options to ena...
To date, the complexity of the plasma proteome exceeds the analytical capacity of conventional appro...
AbstractOff-line sample prefractionations applied prior to biomarker discovery proteomics are option...
Serum is the body fluid most often used in biomarker discovery. Albumin, the most abundant serum pro...
BACKGROUND: To date, the complexity of the plasma proteome exceeds the analytical capacity of conve...
Discovery and validation of plasma biomarkers are quite challenging because of the high complexity a...
Characterisation of blood serum peptides can provide valuable information on physiological and patho...
Serum potentially carries an archive of important histo-logical information whose determination coul...
Changes in serum proteins that signal histopathological states, such as cancer, are useful diagnosti...
The enormous depth complexity of the human plasma proteome poses a significant challenge for current...
mAb proteomics, a reversed biomarker discovery approach, is a novel methodology torecognize the prot...
Serum provides a rich source of potential biomarker proteoforms. One of the major obstacles in analy...